|
|
|
市场调查报告书
全球的皮肤科处方药市场：第7版
The Worldwide Market for Prescription Dermatological Drugs, 7th Edition
|
本报告已在2012年04月20日停止出版。
更改为出版
World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
出版日期 : 2012年03月
商品编码: 233324
本报告，详细分析各种种类的皮肤科处方药，汇整各个的市场规模与研发动向、未来的预测，并提供参与市场企业的档案数据，由下列摘要形式阐述。
第1章 报告摘要
第2章 简介
- 皮肤的构造与功能
- 老化对皮肤的影响
- 皮肤的症状与治疗
- 药物动力学
- 药物投递方法
- 皮肤疾病、罹患率
第3章 课题与趋势
- 病患顺从度
- 美容人口
- 黑色素瘤活存率
- 磷酸醯甘油与牛皮癣 其他
第4章 青春痘治疗与酒糟鼻治疗的处方药
- 疾病的概要
- 产品概要
- 研发
- 市场规模与成长
- 市场的未来
- 竞争分析
第5章 抗老化与光害的处方药
- 概要
- 产品概要
- 研发
- 市场规模与成长
- 市场的未来
- 竞争分析
第6章 皮肤炎以及皮脂漏症治疗的处方药
- 概要
- 产品概要
- 研发
- 市场规模与成长
- 市场的未来
- 竞争分析
第7章 抗真菌处方药
- 概要
- 产品概要
- 研发
- 市场规模与成长
- 市场的未来
- 竞争分析
第8章 掉毛・除毛处方药
- 概要
- 产品概要
- 研发
- 市场规模与成长
- 市场的未来
- 竞争分析
第9章 色素沉著以及肝斑治疗的处方药
- 概要
- 产品概要
- 研发
- 市场规模与成长
- 市场的未来
- 竞争分析
第10章 牛皮癣治疗的处方药
- 概要
- 产品概要
- 研发
- 市场规模与成长
- 市场的未来
- 竞争分析
第11章 皮肤癌治疗的处方药
- 概要
- 产品概要
- 研发
- 市场规模与成长
- 市场的未来
- 竞争分析
第12章 其他皮肤疾病
第13章 全球市场摘要
第14章 企业档案数据
附录：企业指南
图表
Abstract
Full Coverage of Nine Prescription Dermatological Drug Segments
The global market for prescription dermatology drugs includes products in the
following categories:
- Prescription Acne and Rosacea Drugs (Benzoyl, Retinoids, Antibiotics,
Other)
- Prescription Antiaging and Photodamage Drugs (Keratolytics, Moisturizers,
Retinoids, Sun-screens, Other Agents)
- Prescription Dermatitis and Seborrhea Drugs(Topical, Systemic, Others)
- Prescription Fungal Infection Drugs (Topical, Systemic)
- Prescription Hair Loss and Hair Removal Drugs(Antiandrogens, Androgen
Inhibitors, Others)
- Prescription Hyperpigmentation/Melasma Drugs(Hyperpigmentation/Melasma
Agents, Depigmenting Agents)
- Prescription Psoriasis Drugs (Topical, Systemic, Other)
- Prescription Skin Cancer Drugs
- Other Prescription Skin Disorder Drugs(Antiviral Drugs, Antiparasitic
Agents)
A Shift to Cosmetic Medications
The pharmaceutical industry is facing a tougher environment in general, due to
harder regulations for gaining approvals for mainstream products, economic
issues, and a dwindling pipeline of new products. Reliance on blockbuster
drugs is all but over, causing a shift of focus for many drug research and
development entities. By focusing on cosmetic medications, many manufacturers
are realizing less scrutiny from the FDA and a growing need in the niche
markets such as dermatology.
This transition will play a role in the future development of the
dermatological industry over the forecast period. The global pharmaceutical
sector has little choice but to continue expanding through mergers and
acquisitions for some time to come.
A Look at Key Trends in Dermatologics
It' s a very dynamic time for the prescription dermatological drug industry.
Consolidation, economic times, new technologies and genetic discoveries are
among the trends that the industry is seeing, and these are among those
analyzed in this report:
- Economic Downturn: The prescription dermatological drug industry was not
immune to the recent economic downturn. Some product categories fared better
than others, and these areas are detailed in the report.
- Cosmetic Dermatologists: The report discusses the debate over a new
function for dermatologists in cosmetic procedures.
- Patient Compliance: Drugs are only effective if patients comply with
dosage and time of administration. This is an increasing concern for
dermatologists and the industry.
- Melanoma Survival Rates Falter: While some other cancers have declined in
incidence, melanoma remains a growing problem, and new dermatological aids
will be in demand.
- Phosphatidylglycerol and Psoriasis: Researchers now understand more about
this lipid and how it may affect psoriasis.
- New Itch Gene Found: One of many genetic discoveries in the dermatological
field recently, the GRPR discovery could have clinical implications soon.
- New Filler Options: Collagen has been used for twenty years; now two new
filler products are being developed and more could be on the way.
- Consumer Confusion: This is a highly competitive market. With information
overload on product choices, its up to the industry to educate.
- Genetic Link to Psoriasis: Discovery of a possible block to the pathway
that activates T cells could change treatment.
- Rx-to-OTC Switches: Several dermatological products that were prescription
are now available OTC.
- Cosmeceuticals: New personal care products, incorporating antioxidants and
polypeptides, go beyond topical moisturizers and anti-wrinkle creams will be a
factor in this market.
- Teledermatology: The taking of and sending of digital pictures for
consultation has changed medical practice in this specialty.
- Reimbursement Issues: The coverage of dermatological drugs can vary be
limited.
- Laser Therapy: While no replacement for prescription dermatological drugs,
these technologies may compliment dermatological treatment.
- Narrowband Ultraviolet B: A new treatment option for actinic prurigo,
solar urticaria and cutaneous porphyria has recently become available.
- Photodynamic Therapy: A possible replacement for surgical excision of
primary skin cancer.
- Synthetic Lipids for Skin Healing: pseudoceramides that are involved in
skin cell growth could be used in treating skin diseases in which skin cells
grow abnormally
- Importance of Drug Delivery: Microdermabrasion and novel electrophoretic
products are among the delivery systems that could be seen in future products.
- New Oral Medications for Acne: extended release minocycline, pre-treatment
antibiotics and other drugs are an option.
- Industry Consolidation:The last couple of years has seen a huge
consolidation effort going in the pharmaceutical industry. Many top
pharmaceutical companies face a deficit in their pipelines and the U.S. Food
and Drug Administration is taking a more conservative approach in approving
new medicines
- PYCR1 gene: Scientists may have discovered a link between this gene and
skin aging. This discovery could open the door for new discoveries in
pharmaceuticals that could mediate the protein in individuals with the gene
mutation.
The information and analysis presented in this report are based on extensive
interviews with senior management of top companies in the dermatology market.
Background information was obtained from a comprehensive search of published
literature and reports obtained from various government, business, medical
trade, and international journals. Key information from published literature
was used to conduct interviews with over 42 industry executives and product
managers to validate and obtain expert opinion on current and future trends in
the dermatological market. Interviews were also used to confirm and/or adjust
market size estimates, as well as in formulating market projections.
The following companies are profiled in this report:
Allergan Inc. Allergan Inamed Corporation Barrier Therapeutics, Inc Bayer AG
PharmaDerm Pharmaceuticals, Inc Bristol-Myers Squibb Collagenex (now Galderma)
Pharmaceuticals Galderma S.A. Genentech, Inc. GlaxoSmithKline Plc Johnson &
Johnson (Janssen Pharmaceutica, Ortho Dermatological, Ortho-McNeil) Medicis
Pharmaceutical Corporation Merck & Company, Inc. Mylan Pharmaceuticals, Inc,
Novartis Pharmaceuticals Corporation Nycomed Inc. Pfizer, Inc. Q-Med AB Roche
Group (F. Hoffmann-La Roche Ltd.) Schering (now Merck)-Plough Corporation
Sinclair Pharma Plc. SkinMedica Stiefel Laboratories, Inc. Valeant
Pharmaceuticals, Inc.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
- Introduction
- Scope and Methodology
- Size and Growth of the Market
- Issues and Trends Affecting Market
- Competitor Analysis
CHAPTER TWO: INTRODUCTION
- Structure and Function of the Skin
- Epidermis
- Dermis
- Subcutaneous Tissue
- Epidermal Appendages
- Functions of the Skin
- Effects of Aging on the Skin
- Dermatological Conditions and Treatment
- Pharmacokinetics
- Drug Absorption
- Distribution
- Bioavailability
- Drug Delivery Methods
- Demographics of Skin Disorders, Incidence, and Prevalence
CHAPTER THREE: ISSUES AND TRENDS
- Patient Compliance
- Cosmetic Dermatologists
- Melanoma Survival Rates Falter
- Phosphatidylglycerol and Psoriasis
- New Itch Gene Found
- New Filler Options
- Consumer Confusion
- Genetic Link to Psoriasis
- Biologic Dermatology
- Rx-to-OTC Switches
- Cosmeceuticals
- Antioxidants
- Polypeptides
- Teledermatology
- Reimbursement Issues
- Accutane IPledge Program
- Laser Therapy
- Narrowband Ultraviolet B
- Photodynamic Therapy
- New Oral Medications and Research for Acne
- Synthetic Lipids for Skin Healing
- Importance of Drug Delivery
CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS
- Description of Disorders
- Description of Products
- Benzoyl Peroxide
- Description of Products
- Current Suppliers
- Retinoids
- Topical Formulations
- Systemic Formulations
- Current Suppliers
- Antibiotics
- Description of Products
- Current Suppliers
- Oral Contraceptives
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS
- Overview
- Description of Products
- Keratolytics
- Moisturizers
- Retinoids
- Sunscreens
- Other Agents
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS
- Overview
- Description of Products
- Topical Corticosteroids
- Systemic Corticosteroids
- Other Products
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS
- Overview
- Description of Products
- Systemic Formulations
- Terbinafine
- Itraconazole
- Fluconazole
- Griseofulvin
- Ketoconazole
- Current Suppliers
- Topical Formulations
- Polyenes
- Azoles
- Allylamines and Benzylamines
- Other Topical Formulations
- New Products
- Current Suppliers
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS
- Overview
- Description of Products
- Antiandrogens
- Androgen Inhibitors
- Oral Contraceptives
- Other Treatments
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION / MELASMA DRUGS
- Overview
- Description of Products
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS
- Overview
- Description of Products
- Topical Psoriasis Products
- Anthralin
- Coal Tar
- Methoxsalen
- Second-generation Retinoids
- Tazarotene
- Topical Vitamin D
- Vitamin D Analogs
- Vanos
- Systemic Psoriasis Preparations
- Betamethasone
- Cortisone Acetate
- Cyclosporine
- Hydrocortisone
- Methotrexate
- Olopatadine Hydrochloride
- Tacrolimus
- Light Therapy
- Biologics
- Research and Development
- Market Size and Growth
- Global Market by Type
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- Future of the Market
- Competitive Analysis
CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS
- Overview
- Nonmelanoma Skin Cancers
- Actinic Keratoses
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Cutaneous T-cell Lymphoma
- Dysplastic Nevus Syndrome
- Malignant Melanoma
- Description of Products
- 5-Fluorouracil
- Mechlorethamine/Nitrogen Mustard
- Carmustine/BCNU (Topical)
- Vinblastine (Intralesional) and Others
- Research and Development
- Market Size and Growth
- Global Market
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS - ANTIVIRALS AND ANTIPARASITICS
- Overview
- Antivirals
- Antiparasitics
- Description of Products
- Topical Antivirals
- Antiviral Drugs
- Immunoenhancing Drugs
- Current Suppliers
- Antiparasitic Agents
- Other Skin Related Products
- Research and Development
- Market Size and Growth
- Markets by Geographical Region
- United States
- Europe
- Japan
- Rest of World
- The Future of the Market
- Competitive Analysis
CHAPTER THIRTEEN: WORLD MARKET SUMMARY
- Overview
- Total Market Size and Forecast
- Market and Competitive Analysis
CHAPTER FOURTEEN: CORPORATE PROFILES
- Allergan Inc
- Allergan Inamed Corporation
- Barrier Therapeutics, Inc
- Bayer AG
- PharmaDerm Pharmaceuticals, Inc
- Bristol-Myers Squibb
- Collagenex (now Galderma) Pharmaceuticals
- Galderma S.A
- Genentech, Inc
- GlaxoSmithKline Plc
- Johnson & Johnson (Janssen Pharmaceutica, Ortho Dermatological,
Ortho-McNeil)
- Medicis Pharmaceutical Corporation
- Merck & Company, Inc
- Mylan Pharmaceuticals, Inc,
- Novartis Pharmaceuticals Corporation
- Nycomed Inc
- Pfizer, Inc
- Q-Med AB
- Roche Group (F. Hoffmann-La Roche Ltd.)
- Schering (now Merck)-Plough Corporation
- Sinclair Pharma Plc
- SkinMedica
- Stiefel Laboratories, Inc
- Valeant Pharmaceuticals, Inc
APPENDIX: Company Directory
TABLE OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: The Global Market for Prescription Dermatological Drugs 2001,
2006, and 2011
Figure 1-1: The Global Market for Prescription Dermatological Drugs 2001,
2006, and 2011
CHAPTER TWO: INTRODUCTION
- Table 2-2: Worldwide Incidence and Prevalence of Selected Dermatologic
Conditions
CHAPTER three: Issues and Trends
- Table 3-1: Selected Dermatological Rx-to-OTC Switches
CHAPTER FOUR: PRESCRIPTION ANTIACNE AND ROSACEA DRUGS
- Table 4-1: Common Benzoyl Peroxide Formulations
- Table 4-2: Common Retinoid Formulations
- Table 4-3: Common Antibiotic Formulations
- Table 4-4: Common Oral Contraceptive Formulations
- Table 4-5: Prescription Acne, Actinic Keratosis and Rosacea Formulations
in Development
- Table 4-6: The Global Market for Prescription Acne and Rosacea Drugs by
Type 2001-2011
- Figure 4-1: The Global Market for Prescription Acne and Rosacea Drug
Revenues by Type, 2001-2011 70
- Figure 4-2: The Global Market for Prescription Acne and Rosacea Drugs
Share by Type 2006
- Figure 4-3: The Global Market for Prescription Acne and Rosacea Drugs
Share by Type 2011
- Table 4-7: The Global Market for Prescription Antiacne and Rosacea Drugs
by Geographical Region 2001-2011
- Figure 4-4: The Global Market for Prescription Antiacne and Rosacea Drugs
Revenues by Geographical Region 2001-2011
- Figure 4-5: The Global Market for Prescription Antiacne and Rosacea Drugs
Share by Geographical Region 2006
- Figure 4-6: The Global Market for Prescription Antiacne and Rosacea Drugs
Share by Geographical Region 2011
- Table 4-8: Global Market for Prescription Antiacne and Rosacea Drugs
Revenues and Market Share by Supplier 2006
- Figure 4-7: Global Market for Acne and Rosacea Drugs Market Share by
Leading Supplier 2006
CHAPTER FIVE: PRESCRIPTION ANTIAGING AND PHOTODAMAGE DRUGS
- Table 5-1: Common Prescription Keratolytic Formulations
- Table 5-2: Occlusive Moisturizers - Categories of Ingredients
- Table 5-3: Common Prescription Moisturizers
- Table 5-4: Common Prescription Retinoids for Antiaging and Photodamage
- Table 5-5: Common Prescription Sunscreens
- Table 5-6: Other Prescription Antiaging and Photodamage Products
- Table 5-7: Prescription Antiaging and Photodamage Formulations in
Development
- Table 5-8: The Global Market Antiaging and Photodamage Drugs by Type
2001-2011
- Figure 5-1: The Global Market for Antiaging and Photodamage Drugs Revenues
by Type 2001-2011
- Figure 5-2: The Global Market for Antiaging and Photodamage Drugs Share by
Type 2006
- Figure 5-3: The Global Market for Antiaging and Photodamage Drugs Share by
Type 2011
- Table 5-9: The Global Market for Prescription Antiaging and Photodamage
-Drugs by Geographical Region 2001-2011
- Figure 5-4: The Global Market for Prescription Antiaging and Photodamage
Drugs, Revenues by Geographical Region 2001-2011
- Figure 5-5: The Global Market for Antiaging and Photodamage Drugs Share by
Geographical Region 2006
- Figure 5-6: The Global Market for Antiaging and Photodamage Drugs Share by
Geographical Region 2011
- Table 5-10: Global Market for Prescription Antiaging and Photodamage Drugs
Revenues and Market Share by Supplier 2006
- Figure 5-7: Global Market for Prescription Antiaging and Photodamage
Drugs, Market Share by Leading Supplier 2006
CHAPTER SIX: PRESCRIPTION DERMATITIS AND SEBORRHEA DRUGS
- Table 6-1: Common Prescription Topical Corticosteroid Preparations
- Table 6-2 Common Prescription Systemic Corticosteroids
- Table 6-3: Prescription Other Dermatitis Formulations
- Table 6-4: Prescription Dermatitis Formulations in Development
- Table 6-5: The Global Market for Prescription Dermatitis and Seborrhea
Drugs by Type 2001-2011
- Figure 6-1: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Revenues by Type 2001-2011
- Figure 6-2: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Share by Type 2006
- Figure 6-3: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Share by Type 2011
- Table 6-6: The Global Market for Prescription Dermatitis and Seborrhea
Drugs by Geographical Region 2001-2011
- Figure 6-4: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Revenues by Geographical Region 2001-2011
- Figure 6-5: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Share by Geographical Region 2006
- Figure 6-6: The Global Market for Prescription Dermatitis and Seborrhea
Drugs Share by Geographical Region 2011
- Table 6-7: Global Market for Prescription Dermatitis and Seborrhea Drugs
Revenues and Market Share by Supplier 2006
- Figure 6-7: Global Market for Prescription Dermatitis and Seborrhea Drugs
Market Share by Leading Supplier 2006
CHAPTER SEVEN: PRESCRIPTION ANTIFUNGAL DRUGS
- Table 7-1: Common Prescription Systemic Antifungal Dermatological
Formulations
- Table 7-2: Common Prescription Topical Antifungal Dermatological Drugs
- Table 7-3: Prescription Antifungal Dermatological Drugs in Development
- Table 7-4: The Global Market for Prescription Antifungal Dermatological
Drugs by Type 2001-2011 152
- Figure 7-1: The Global Market for Prescription Antifungal Dermatological
Drugs Revenues by Type 2001-2010
- Figure 7-2: The Global Market for Prescription Antifungal Dermatological
Drugs Share by Type 2006 154
- Figure 7-3: The Global Market for Prescription Antifungal Dermatological
Drugs, Share by Type 2011
- Table 7-5: The Global Market for Prescription Antifungal Dermatological
Drugs by Geographical Region 2001-2011
- Figure 7-4: The Global Market for Prescription Antifungal Dermatological
Drugs Revenues by Geographical Region 2001-2011
- Figure 7-5: The Global Market for Prescription Antifungal Dermatological
Drugs, Share by Geographical Region 2006
- Figure 7-6: The Global Market for Prescription Antifungal Dermatological
Drugs, Share by Geographical Region 2011
- Table 7-6: Global Market for Prescription Antifungal Dermatological Drugs
Revenues and Market Share by Supplier 2006
- Figure 7-7: Global Market for Prescription Antifungal Dermatological Drugs
Market Share by Leading Supplier 2006
CHAPTER EIGHT: PRESCRIPTION HAIR LOSS AND HAIR REMOVAL DRUGS
- Table 8-1: Common Prescription Hair Loss or Hair Removal Formulations
- Table 8-2: Prescription Hair Loss or Hair Removal Formulations in
Development 170
- Table 8-3: The Global Market for Prescription Hair Loss and Hair Removal
Drugs by Type 2001-2011
- Figure 8-1: The Global Market for Prescription Hair Loss and Hair Removal
Drugs Revenues by Type 2001-2011
- Figure 8-2: The Global Market for Prescription Hair Loss and Hair Removal
Drugs, Share by Type 2006
- Figure 8-3: The Global Market for Prescription Hair Loss and Hair Removal
Drugs, Share by Type 2011
- Table 8-4: The Global Market for Prescription Hair Loss and Hair Removal
Drugs Revenues by Geographical Region 2001-2011
- Figure 8-4: The Global Market for Prescription Hair Loss and Hair Removal
Drugs Revenues by Geographical Region 2001-2011
- Figure 8-5: The Global Market for Prescription Hair Loss and Hair Removal
Drugs Share by Geographical Region 2006
- Figure 8-6: The Global Market for Prescription Hair Loss and Hair Removal
Drugs Share by Geographical Region 2011
- Table 8-5: Global Market for Prescription Hair Loss and Hair Removal Drugs
Revenues and Market Share by Supplier 2006
- Figure 8-7: Global Market for Prescription Hair Loss and Hair Removal
Drugs Market Share by Leading Supplier 2006
CHAPTER NINE: PRESCRIPTION HYPERPIGMENTATION/MELASMA DRUGS
- Table 9-1: Common Prescription Hyperpigmentation/Melasma Formulations
- Table 9-2: Common Prescription Depigmenting Agents
- Table 9-3: The Global Market for Hyperpigmentation/Melasma Drugs by Type
2001-2011
- Figure 9-1: The Global Market for Hyperpigmentation/Melasma Drugs Revenues
by Type 2001-2011
- Figure 9-2: The Global Market for Prescription Hyperpigmentation/ Melasma
Drugs, Share by Type 2006
- Figure 9-3: The Global Market for Prescription Hyperpigmentation/ Melasma
Drugs Share by Type 2011
- Table 9-4: The Global Market for Prescription Hyperpigmentation/ Melasma
Drugs by Geographical Region 2001-2011
- Figure 9-4: The Global Market for Prescription Hyperpigmentation/ Melasma
Drugs Revenues by Geographical Region 2001-2011
- Figure 9-5: The Global Market for Prescription Hyperpigmentation/ Melasma
Drugs, Share by Geographical Region 2006
- Figure 9-6: The Global Market for Prescription Hyperpigmentation/ Melasma
Drugs, Share by Geographical Region 2011
CHAPTER TEN: PRESCRIPTION PSORIASIS DRUGS
- Table 10-1: Common Prescription Psoriasis Preparations
- Table 10-2: Prescription Psoriasis Preparations in Development
- Table 10-3: The Global Market for Prescription Psoriasis Drugs by Type
2001-2011
- Figure 10-1: The Global Market for Prescription Psoriasis Drugs Revenues
by Type 2001-2011
- Figure 10-2: The Global Market for Prescription Psoriasis Drugs Share by
Type 2006
- Figure 10-3: The Global Market for Prescription Psoriasis Drugs Share by
Type 2011
- Table 10-4: The Global Market for Prescription Psoriasis Drugs by
Geographical Region 2001-2011 227
- Figure 10-4:The Global Market for Prescription Psoriasis Drugs Revenues by
Geographical Region 2001-2011
- Figure 10-5: The Global Market for Prescription Psoriasis Drugs Share by
Geographical Region 2006
- Figure 10-6: The Global Market for Prescription Psoriasis Drugs Share by
Geographical Region 2011
- Table 10-5: Global Market for Prescription Psoriasis Drugs Revenues and
Market Share by Supplier 2006 231
- Figure 10-7: Global Market for Prescription Psoriasis Drugs Market Share
by Leading Supplier 2006 231
CHAPTER ELEVEN: PRESCRIPTION SKIN CANCER DRUGS
- Table 11-1: Malignant Conditions of the Skin
- Table 11-2: Common Prescription Topical and Intralesional Chemotherapeutic
Agents
- Table 11-3: Prescription Skin Cancer Preparations in Development
- Table 11-4: The Global Market for Skin Cancer Drugs 2001-2011
- Figure 11-1: The Global Market for Skin Cancer Drugs 2001-2011
- Table 11-5: The Global Market for Prescription Skin Cancer Drugs by
Geographical Region 2001-2011 247
- Figure 11-2: The Global Market for Prescription Skin Cancer Drugs Revenues
by Geographical Region 2001-2011
- Figure 11-3: The Global Market for Prescription Skin Cancer Drugs Share by
Geographical Region 2006
- Figure 11-4: The Global Market for Prescription Skin Cancer Drugs Share by
Geographical Region 2011
- Table 11-12: Global Market for Prescription Skin Cancer Drugs Revenues and
Market Share by Supplier 2006
- Figure 11-5: Global Market for Skin Cancer Drugs Market Share by Leading
Supplier 2006
CHAPTER TWELVE: MISCELLANEOUS SKIN DISORDER DRUGS --ANTIVIRALS AND ANTIPARASITICS
- Table 12-1: Common Prescription Topical Antiviral Formulations
- Table 12-2: Common Prescription Topical Antiparasitic Formulations
- Table 12-3: Prescription Miscellaneous Skin Preparations in Development
- Table 12-4: The Global Market for Prescription Miscellaneous Skin Disorder
Drugs by Type 2001-2011
- Figure 12-1: The Global Market for Miscellaneous Skin Disorder Drugs -
Revenues by Type 2001-2011
- Figure 12-2: The Global Market for Miscellaneous Skin Disorder Drugs Share
by Type 2006
- Figure 12-3: The Global Market for Miscellaneous Skin Disorder Drugs Share
by Type 2011
- Table 12-6: The Global Market for Prescription Miscellaneous Drugs by
Geographical Region 2001-2011 268
- Figure 12-4: The Global Market for Prescription Miscellaneous Drugs
Revenues by Geographical Region 2001-2011
- Figure 12-5: The Global Market for Prescription Miscellaneous Drugs ..
Share by Geographical Region 2006
- Figure 12-6: The Global Market for Prescription Miscellaneous Drugs Share
by Geographical Region 2011
CHAPTER THIRTEEN: WORLD MARKET SUMMARY
- Table 13-1: The Global Market for Prescription Dermatological Drugs,
Revenues by Segment, 2001-2011
- Figure 13-1: The Global Market for Prescription Dermatological Drugs
Revenues by Dermatological Segment 2001-2011
- Figure 13-2: The Global Market for Dermatological Drugs Market Share by
Type 2006
- Figure 13-3: The Global Market for Dermatological Drugs Market Share by
Type 2011
- Table 13-3: Global Market for Prescription Dermatological Drugs Revenues
and Segments of Participation by Leading Market Participants 2006
|
 |
